Northstar Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$2.63M Sell
10,370
-331
-3% -$82K 1.23% 27
2020
Q2
$2.52M Buy
10,701
+420
+4% +$95.8K 1.05% 27
2020
Q1
$2.08M Sell
10,281
-234
-2% -$51.1K 1.06% 28
2019
Q4
$2.53M Hold
10,515
1.04% 27
2019
Q3
$2.04M Buy
10,515
+34
+0.3% +$6.53K 0.89% 35
2019
Q2
$1.93M Buy
10,481
+319
+3% +$57.1K 0.86% 37
2019
Q1
$1.93M Buy
10,162
+200
+2% +$38.2K 0.88% 37
2018
Q4
$1.94M Sell
9,962
-75
-0.7% -$14.6K 1.02% 30
2018
Q3
$2.08M Buy
10,037
+2,356
+31% +$464K 1% 31
2018
Q2
$1.42M Hold
7,681
0.71% 46
2018
Q1
$1.31M Buy
+7,681
New +$1.41M 0.67% 46

Other funds holding AMGN

Northstar Wealth Partners's AMGN Position: Q3 2020 in Review

Northstar Wealth Partners reduced its Amgen (AMGN) stake by 3.1% in Q3 2020, selling an estimated $82K and leaving 10,370 shares worth $2.63M. The position accounts for 1.23% of the portfolio, ranked #27.

Northstar Wealth Partners first reported a position in AMGN in Q1 2018 and has held it in 11 quarters since. 2,128 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Northstar Wealth Partners held 10,370 shares of Amgen worth $2.63M as of Q3 2020.
  • Northstar Wealth Partners sold 331 Amgen shares in Q3 2020, an estimated $82K.
  • Amgen made up 1.23% of Northstar Wealth Partners's portfolio in Q3 2020, its #27 holding.
  • Northstar Wealth Partners first reported a position in Amgen in Q1 2018 and has held it in 11 quarters since.
  • 2,128 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Northstar Wealth Partners's 13F filing for Q3 2020, filed 13 Nov 2020.